Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Centhaquine

From Wikipedia, the free encyclopedia
Cardiovascular medication

Pharmaceutical compound
Centhaquine
Clinical data
Trade namesLyfaquin
Other namesCenthaquin; PMZ-2010; Compound-7173
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 2-[2-[4-(3-Methylphenyl)piperazin-1-yl]ethyl]quinoline
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC22H25N3
Molar mass331.463 g·mol−1
3D model (JSmol)
  • CC1=CC(=CC=C1)N2CCN(CC2)CCC3=NC4=CC=CC=C4C=C3
  • InChI=InChI=1S/C22H25N3/c1-18-5-4-7-21(17-18)25-15-13-24(14-16-25)12-11-20-10-9-19-6-2-3-8-22(19)23-20/h2-10,17H,11-16H2,1H3
  • Key:UJNWGFBJUHIJKK-UHFFFAOYSA-N

Centhaquine (brand nameLyfaquin) is a cardiovascular drug.[1] In India, it is approved for the treatment ofhypovolemic shock.[2]

Centhaquine is avasopressor that activatesα2A- andα2B-adrenoreceptors.[3] It increasesvenous return and improvestissue perfusion. The drug has more recently been identified as apotent andselectiveserotonin5-HT2C receptoragonist (EC50Tooltip half-maximal effective concentration = 35 nM).[4] It has no detectable activity at the serotonin5-HT2B or5-HT2C receptors.[4]

References

[edit]
  1. ^Gulati A, Jain D, Agrawal NR, Rahate P, Choudhuri R, Das S, et al. (June 2021)."Resuscitative Effect of Centhaquine (Lyfaquin®) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial".Advances in Therapy.38 (6):3223–3265.doi:10.1007/s12325-021-01760-4.PMC 8189997.PMID 33970455.
  2. ^"Marketing authorization received for Lyfaquin (centhaquine) to treat patients with hypovolemic shock from Indian regulatory agency" (Press release). May 14, 2020.Archived from the original on August 9, 2022. RetrievedApril 25, 2024.
  3. ^Chalkias A, Pais G, Gulati A (March 2024)."Effect of Centhaquine on the Coagulation Cascade in Normal State and Uncontrolled Hemorrhage: A Multiphase Study Combining Ex Vivo and In Vivo Experiments in Different Species".International Journal of Molecular Sciences.25 (6): 3494.doi:10.3390/ijms25063494.PMC 10970680.PMID 38542464.
  4. ^abAdhikari AS, Yadav A, Pandit S, Kumar S, Pandey VK, Maurya AK, et al. (26 November 2025)."Synthesis and Evaluation of Novel Aza-Aromatics as Dual 5-HT2A and 5-HT2C Receptor Agonists".ACS Medicinal Chemistry Letters acsmedchemlett.5c00505.doi:10.1021/acsmedchemlett.5c00505.ISSN 1948-5875. Retrieved29 November 2025.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Stub icon

Thisdrug article relating to theblood andblood forming organs is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Centhaquine&oldid=1329434814"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp